RG
Redmile Group’s Jazz Pharmaceuticals JAZZ Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-341,882
| Closed | -$42.4M | – | 72 |
|
|
2023
Q2 | $42.4M | Buy |
341,882
+6,723
| +2% | +$833K | 1.63% | 19 |
|
|
2023
Q1 | $49M | Buy |
335,159
+16,214
| +5% | +$2.37M | 2.13% | 15 |
|
|
2022
Q4 | $50.8M | Buy |
318,945
+237,481
| +292% | +$37.8M | 2.08% | 16 |
|
|
2022
Q3 | $10.9M | Sell |
81,464
-11,800
| -13% | -$1.57M | 0.42% | 49 |
|
|
2022
Q2 | $14.6M | Sell |
93,264
-21,500
| -19% | -$3.35M | 0.56% | 45 |
|
|
2022
Q1 | $17.9M | Buy |
114,764
+16,700
| +17% | +$2.6M | 0.56% | 45 |
|
|
2021
Q4 | $12.5M | Sell |
98,064
-763,337
| -89% | -$97.2M | 0.28% | 56 |
|
|
2021
Q3 | $112M | Buy |
861,401
+1,300
| +0.2% | +$169K | 1.96% | 18 |
|
|
2021
Q2 | $153M | Buy |
860,101
+30,942
| +4% | +$5.5M | 2.26% | 12 |
|
|
2021
Q1 | $136M | Buy |
+829,159
| New | +$136M | 1.92% | 14 |
|
|
2019
Q4 | – | Sell |
-187,599
| Closed | -$24M | – | 70 |
|
|
2019
Q3 | $24M | Buy |
187,599
+19,212
| +11% | +$2.46M | 0.8% | 40 |
|
|
2019
Q2 | $24M | Sell |
168,387
-101,093
| -38% | -$14.4M | 0.68% | 44 |
|
|
2019
Q1 | $38.5M | Buy |
269,480
+132,800
| +97% | +$19M | 1.13% | 29 |
|
|
2018
Q4 | $16.9M | Buy |
136,680
+135,090
| +8,496% | +$16.7M | 0.68% | 46 |
|
|
2018
Q3 | $267K | Hold |
1,590
| – | – | 0.01% | 78 |
|
|
2018
Q2 | $274K | Buy |
+1,590
| New | +$274K | 0.01% | 74 |
|
|
2015
Q4 | – | Sell |
-1,769
| Closed | -$235K | – | 61 |
|
|
2015
Q3 | $235K | Sell |
1,769
-149,097
| -99% | -$19.8M | 0.02% | 55 |
|
|
2015
Q2 | $26.6M | Buy |
150,866
+50,866
| +51% | +$8.96M | 2.18% | 16 |
|
|
2015
Q1 | $17.3M | Buy |
+100,000
| New | +$17.3M | 1.55% | 23 |
|
|
2014
Q2 | – | Sell |
-142,886
| Closed | -$19.8M | – | 53 |
|
|
2014
Q1 | $19.8M | Sell |
142,886
-39,675
| -22% | -$5.5M | 2.37% | 18 |
|
|
2013
Q4 | $23.1M | Buy |
+182,561
| New | +$23.1M | 2.85% | 8 |
|